Markets are efficient to the extent that information is gathered, analysed and acted upon. Where the incentive to do that work disappears, so does much of the efficiency. That is the structural reason smaller listed companies can trade a long way from any reasonable estimate of value, in both directions, for extended periods.
Coverage is the first cause. Sell-side research is funded by the revenue it generates, and a company too small to support meaningful trading volume or corporate activity cannot justify an analyst’s time. Once coverage falls to one or two houses, or none, there is no consensus estimate, no earnings model in circulation, and often no published explanation of the business at all. Information has not become unavailable — it is in the accounts — but nobody is paid to interpret it. Pricing then reflects whoever happens to be trading rather than any considered view of the business.
Liquidity compounds the effect. Institutional investors face position-size constraints as a matter of policy: a fund may be unable to build a holding it could not exit in a reasonable number of days, or unable to hold more than a set percentage of a company’s issued capital. This removes a large body of informed buyers regardless of how attractive the business is. The consequence is that price is set at the margin by a small number of participants, and that modest flows — an index change, a single seller reducing a legacy position, a small placement — move valuations far more than any change in underlying performance.
Communication is the cause most within a company’s control, and the one most often mishandled. Smaller companies frequently report accurately and explain nothing. Results arrive without commentary on what drove them. Divisional performance is aggregated beyond usefulness. There is no investor presentation, no transcript, no practical way for a prospective shareholder to understand unit economics without reconstructing them from a decade of filings. Boards sometimes treat this reticence as prudence. In practice it is a self-imposed cost of capital: investors discount what they cannot verify.
For an investor willing to do primary work, these conditions create genuine opportunity, but the distinction that matters is between neglect and justified low valuation. Some companies are cheap because nobody is looking. Others are cheap because the business is structurally poor, the balance sheet is fragile, or the controlling shareholder has no interest in the minority’s outcome. The first can be a durable source of return. The second is usually a value trap, and no amount of analysis converts one into the other.
The practical discipline is therefore unromantic. Read the full history rather than the current year. Reconstruct the cash flows rather than accepting adjusted earnings. Understand the register, and who is actually in a position to make decisions. Establish whether the business would be sound if the share price never re-rated, because in illiquid markets the re-rating may take years and may arrive only when a catalyst — a result, a change of management, a transaction — forces other participants to look.
Inefficiency is not a strategy in itself. It is the condition that makes patient, independent analysis worth doing.
Nothing published in Insights is personal financial advice, an offer of securities, or an invitation to invest with Leopard Asset Management. Commentary is general in nature and may refer to companies, securities or market issues only for the purpose of explaining Leopard’s thinking.